Voltarol Emulgel 1% w/w Gel

Voltarol is a widely recognized brand of topical pain relief treatments, specifically utilizing the active ingredient diclofenac diethylammonium. The brand is the UK and European counterpart to the global 'Voltaren' label. Historically, the formulation was developed by the Swiss pharmaceutical giant Ciba-Geigy, which later became part of Novartis.

Manufacturing for the European and UK markets predominantly takes place in Germany, often at facilities in Munich or at specialised sites in Ireland like Dungarvan, which serves over 70 global markets. Following a major strategic joint venture and subsequent demerger of consumer healthcare divisions between GlaxoSmithKline (GSK) and Pfizer, the brand is now owned by Haleon, a dedicated consumer health company headquartered in the United Kingdom. Haleon officially became an independent entity in 2022, managing a portfolio of major household brands including Panadol and Sensodyne.